Comparison of tumour segmentation methods for dosimetry in [177Lu]Lu-PSMA I&T treated patients with metastatic castration resistant prostate cancer
{{output}}
Background: Tumour dosimetry after radionuclide therapy using 177Lu-labelled radiopharmaceuticals requires determination of the 177Lu mean concentration, but this is challenging as tumours are often small, or 177Lu activity is pr... ...
